Thrive Capital Management (Pennsylvania)’s iShares US Medical Devices ETF IHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-3,873
Closed -$243K 174
2025
Q2
$243K Buy
+3,873
New +$233K 0.08% 156
2024
Q4
Sell
-8,704
Closed -$516K 131
2024
Q3
$516K Sell
8,704
-81
-0.9% -$4.63K 0.24% 120
2024
Q2
$492K Buy
+8,785
New +$492K 0.23% 128
2024
Q1
Sell
-34,316
Closed -$1.85M 160
2023
Q4
$1.85M Sell
34,316
-2,276
-6% -$111K 0.99% 34
2023
Q3
$1.77M Buy
36,592
+7,045
+24% +$375K 0.98% 33
2023
Q2
$1.67M Sell
29,547
-1,399
-5% -$77.1K 0.95% 32
2023
Q1
$1.64M Sell
30,946
-1,031
-3% -$54.9K 1.04% 28
2022
Q4
$1.68M Sell
31,977
-2,672
-8% -$136K 1.1% 25
2022
Q3
$1.64M Sell
34,649
-1,597
-4% -$82.9K 1.11% 28
2022
Q2
$1.83M Sell
36,246
-920
-2% -$50.1K 1.27% 21
2022
Q1
$2.27M Buy
37,166
+13,826
+59% +$824K 1.37% 21
2021
Q4
$1.54M Buy
+23,340
New +$1.49M 1% 23

Other funds holding IHI